The decreased serum NCAM levels in patients with AUD with and without comorbid depression, is in contrast with a clinical study which found increased PSA-NCAM1 expression in lethally intoxicated patients with opioid use disorder (53). This evidence concerns the gene NCAM1 and depressive symptom measurement.